Semaglutide obesity is the first ST efficacious treatment options to m Phase 3 STEP programme Semaglutide 2.4 mg Placebo Semaglutide 1 mg Semaglutide 2.4 mg Placebo Semaglutide 2.4 mg + intensive behavioural therapy incl. 8 weeks low calorie diet Placebo + intensive behavioural therapy incl. 8 weeks low calorie diet Semaglutide 2.4 mg Semaglutide 2.4 mg Placebo 2019 STEP 1: Weight m n=1,950 Duration: 68 weeks STEP 2: Weight m n=1,200 Duration: 68 weeks STEP 3: Maximisi n=600 Duration: 68 weeks STEP 4: Maintain n=900 Duration: 68 weeks SELECT: Cardiova N=17,500 Event-driven trial with
Download PDF file